CD47 and cancer: come to a similar conclusion that humanized CD47 antibody HU5F9-G4 inhibits CD47 expression, enhanced tumor cell phagocytosis by macrophage, improves the survival time of animals, and has nontoxic effects on neurons and other tissues in a xenograft model derived from the malignant brain tumor (50).